Article and Video CATEGORIES
The first of several podcasts we'll be adding here from our ASCO 2012 Lung Cancer Highlights program, co-sponsored with LUNGevity Foundation, is with Dr. Mark Socinski, Professor at the University of Pittsburgh, who discussed the updated results of continuation maintenance therapy with Alimta (pemetrexed) on the PARAMOUNT trial. Here is his summary of the presentation that now includes data on the overall survival in that study, which demonstrated a significant benefit for the recipients of continuation maintenance Alimta.
Dr. Socinski ASCO LC Highlights PARAMOUNT Trial Audio Podcast
Dr. Socinski ASCO LC Highlights 2012 PARAMOUNT Trial Transcript
Dr. Socinski ASCO LC Highlights 2012 PARAMOUNT Trial Figs
We'll turn out the podcasts from this program in rapid succession. Look for the next one, with Dr. Socinski reviewing an important trial on poor performance status patients with advanced NSCLC, very soon.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Stan,
It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving. I know it meant a...
Hi Stan! It is good to hear from you -- I am so very happy you are doing well. I agree with Janine that family and friends - our chosen family...
Recent Comments
I understand…